TABLE 2.
Data set 1 | Data set 2 | |||||
---|---|---|---|---|---|---|
No HT (n = 250) | HT (n = 88) | p value | No HT (n = 39) | HT (n = 15) | p value | |
Gender (male), n (%) | 165 (66.00%) | 48 (55.55%) | 0.072 | 23 (58.97%) | 8 (53.33%) | 0.765 |
Age (years), mean ± SD | 65.78 ± 9.68 | 70.93 ± 11.29 | <0.001 | 64.22 ± 8.57 | 71.38 ± 10.19 | <0.001 |
Time from MRI to onset (min), mean ± SD | 202.72 ± 77.36 | 218.17 ± 114.19 | 0.159 | 217.19 ± 89.39 | 220.03 ± 102.41 | 0.211 |
Time from EVT to onset (min), mean ± SD | 285.25 ± 137.27 | 314.47 ± 104.56 | 0.070 | 301.36 ± 124.71 | 319.07 ± 128.11 | 0.127 |
Smoking, n (%) | 57 (22.80%) | 16 (18.18%) | 0.452 | 7 (17.95%) | 2 (13.33%) | 1.000 |
Alcohol drinking, n (%) | 25 (10.00%) | 15 (17.05%) | 0.086 | 4 (10.26%) | 2 (13.33%) | 1.000 |
Diabetes mellitus, n (%) | 60 (24.00%) | 25 (28.41%) | 0.475 | 8 (20.51%) | 4 (26.67%) | 0.719 |
Hypertension, n (%) | 197 (78.80%) | 72 (81.82%) | 0.645 | 31 (79.49%) | 12 (80.00%) | 1.000 |
Atrial fibrillation, n (%) | 102 (40.80%) | 46 (52.27%) | 0.080 | 14 (35.90%) | 7 (46.67%) | 0.541 |
Hyperlipidemia, n (%) | 22 (8.80%) | 9 (10.23%) | 0.672 | 3 (7.69%) | 2 (13.33%) | 0.610 |
Homocysteine, n (%) | 18 (7.20%) | 7(7.95%) | 0.815 | 3 (7.69%) | 2 (13.33%) | 0.610 |
NIHSS on admission, n (%) | 10.91 ± 3.87 | 13.90 ± 2.46 | <0.001 | 11.26 ± 4.41 | 14.79 ± 6.65 | <0.001 |
Reperfusion therapy, n (%) | 0.362 | 1.000 | ||||
EVT | 195 (78.00%) | 73 (82.95%) | 30 (76.92%) | 12 (80.00%) | ||
IVT + EVT | 55 (22.00%) | 15 (17.05%) | 9 (23.08%) | 3 (20.00%) |
Abbreviations: EVT, endovascular thrombectomy; HT, hemorrhagic transformation; IVT, intravenous thrombolysis; NIHSS, National Institutes of Health Stroke Scale.